iKinnect2.0 App for Suicide Risk in Youth
Trial Summary
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your healthcare provider.
Research shows that smartphone apps for mental health, like safety planning and self-monitoring apps, are considered usable and acceptable by patients with suicidal thoughts. These apps can help manage suicidal ideation by providing support and strategies, suggesting that similar apps like iKinnect2.0 could be effective in helping youth at risk.
12345The iKinnect2.0 treatment is unique because it uses a mobile app to monitor and assess suicide risk in real-time, allowing for immediate intervention and support, unlike traditional methods that rely on periodic assessments.
678910Eligibility Criteria
This trial is for English-speaking youth aged 15-21 at high risk of suicide, with a history of self-harm or attempts, who use a smartphone with data and live with their primary caregiver. Caregivers must also participate, be fluent in English, and have a smartphone. Youth should be involved in juvenile justice services.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Pilot Testing
Usability and acceptability testing of iKinnect2.0 features with target end-users and stakeholders
Randomized Controlled Trial
Participants are randomly assigned to iKinnect2.0 or Life360 control app for a 16-week trial to test the efficacy of iKinnect2.0 in reducing suicidal behaviors and improving coping strategies
Follow-up
Participants are monitored for safety and effectiveness after the trial